Focal therapy for prostate cancer can preserve potency
Nearly two-hundred-thousand American men are diagnosed with prostate cancer
each year.
And treatments like radiation and surgery often target the entire prostate, even when only part of the gland is cancerous. Aggressive treatment can result in urinary incontinence or loss of potency in some men.
But Duke University Medical Center experts say a pinpointed new surgery called focal therapy is effective in targeting only the cancerous portion of the prostate, sparing surrounding healthy tissue.
Dr. Thomas Polascik
These days theres some concern that many Americans are overtreated for prostate cancer when they may not need such aggressive treatment. So this is a way to preserve bodily functions—most notably continence and potency while attempting to control the cancer.
During focal therapy, the cancerous part of the prostate is treated with cryotherapy, which kills cancer cells by freezing them. The rest of the prostate is left untreated, preserving its function.
One of the benefits of focal therapy is that it can be repeated and what may happen in the future is we may transform prostate cancer into a chronic disease. In other words, if a patient is treated and then has a recurrence many years down the road, that treatment can be repeated.
Doctors say biopsies are periodically needed after therapy to be sure untreated sections of the prostate remain cancer-free.
A recent analysis by Duke surgeons found continence is maintained in nearly 98% of patients who receive focal therapy, and up to 90% of patients maintain potency.
About one in five patients with prostate cancer may be candidates for focal therapy. At the Duke University Medical Center, Im Mike Garrison
Duration : 0:2:14
“I think the emotional preparedness is a key in the recovery after prostate cancer surgery.” Dr. Tewari, of the Dept. of Urology at NewYork-Presbyterian Hospital/Weill Cornell Medical Center, presents an insightful perspective on the emotional dimensions of prostate cancer and the critical role those emotions play in treatment and recovery.
“PSA allows us to detect prostate cancer several years before that nodule would develop, at a much earlier stage, and therefore at a much more curable stage.” Drs. Schlegel (Department Chairman) and Tewari of Cornell Urology discuss the application of PSA tests, digital rectum exams, and other approaches that enable urologists to diagnose prostate cancer earlier. A family history of prostate cancer and the implications relative to a diagnosis of prostate cancer is also discussed. The need to receive a PDA and at what age is also covered by one of the leading prostate cancer researchers.
“There’s no doubt that if the cancer is picked up early, it gives many more treatment options than if it’s picked up later.” Dr. Tewari (leader in prostate cancer research and surgery) of Cornell Urology discusses the critical importance of early detection in prostate cancer and the benefits it has for prostate cancer patients.
“The most important thing to prevent prostate cancer is to pick your parents properly.” Dr. Schlegel (Department Chairman) of Cornell Urology discusses a question they face often—Can prostate cancer be prevented? They discuss the role of race, diet, genetic profile and review important steps we can take to decrease our risk of facing prostate cancer.
“It’s like poking into a pillow in which a couple of golf balls are hidden.” Dr. Tewari, of the Dept. of Urology at NewYork-Presbyterian Hospital/Weill Cornell Medical Center, discusses the prostate cancer biopsy and its effectiveness. While it’s the best they have, it is not perfect.
In this health video minute on prostate cancer, Drs. Tewari (leader in prostate cancer research and surgery) and Schlegel (Department Chairman) of Cornell Urology provide an overview of the advanced surgical techniques that help patients avoid some of the complications ociated with complicated prostate cancer surgery treatment options. Discussions concerning erectile dysfunction and urinary incontinence resulting from prostate cancer surgery are among the potential complications these leaders in prostate cancer surgery and research discuss.
“The outcomes from surgical treatment of prostate cancer are dependent on the patient’s age, on the extent of the tumor, and to some degree the experience and results that an individual surgeon gets.” Dr. Schlegel, of the Dept. of Urology at NewYork-Presbyterian Hospital/Weill Cornell Medical Center, explains common expectations for patients entering into prostate cancer surgery and what factors those expectations are founded upon.
In this health video minute on prostate cancer, Dr. Schlegel (Department Chairman) of Cornell Urology discusses the process a patient enters when evaluating the risks of various treatments for prostate cancer including an acceptance of the risks and a balancing of the benefits. In this prostate cancer health video, the focus is on radiation therapy. This approach may allow patients to avoid major prostate cancer operation, but it is not without risk.
“The key in watchful waiting is not waiting, it’s watchful intervention.” Dr. Tewari, of the Dept. of Urology at NewYork-Presbyterian Hospital/Weill Cornell Medical Center, discusses the fact that surgery and immediate treatment for prostate cancer patients is not the optimal choice for certain prostate cancer patients.